临床试验/NCT00712478

NCT00712478已完成不适用

Observational Study on Efficacy of Intensification of Insulin Therapy to at Least 3 Daily Injections in Type 2 Diabetes

Novo Nordisk A/S0 个研究点目标入组 114 人开始时间: 2007年9月最近更新: 2023年11月2日

适应症

干预措施

试验速览

阶段: 不适用
状态: 已完成
发起方: Novo Nordisk A/S
入组人数: 114
主要终点: Evaluate improvement of diabetes control with fasting glycemia and after diner glycemia measurements

研究概览研究设计入排标准研究组 & 干预措施结局指标研究者记录与标识符相似试验

研究概览

简要总结

This study is conducted in Europe. The aim of this observational study is to determine diabetes control improvement, during the third month of follow-up after insulin intensification to at least 3 daily insulin injections, in assessing the proportion of uncontrolled fasting and postprandial glycaemia values recorded on a diary.

研究设计

研究类型: Observational
观察模型: Cohort
时间视角: Prospective

入排标准

年龄范围: 40 Years 至 —（Adult, Older Adult）
性别: All
接受健康志愿者: 否

入选标准

•Type 2 diabetes patients
•Treatment with two insulin daily injections and needing insulin intensification regimen to at least three daily injections
•HbA1c greater than or equal to 8.0%

排除标准

•Patients not performing glycaemia self-measurements
•Secondary diabetes
•Requirement of or use of an insulin pump
•Treatment with corticoids

研究组 & 干预措施

A

干预措施: insulin (Drug)

结局指标

主要结局

Evaluate improvement of diabetes control with fasting glycemia and after diner glycemia measurements

时间窗: After 3 months

次要结局

Evaluate improvement of diabetes control with fasting glycemia and after diner glycemia measurements(After first 2 months)

研究者

发起方

Novo Nordisk A/S

申办方类型

Industry

责任方

Sponsor

相似试验

已完成

不适用

Observational Study Describing Conditions for Administering Slow-acting Insulin Analogue With Oral Antidiabetic Agents in Type 2 Diabetes on Blood Glucose ControlDiabetesDiabetes Mellitus, Type 2

NCT00700960Novo Nordisk A/S2,745

已完成

不适用

Observational Study on Blood Glucose Control in Patients With Diabetes Using Modern InsulinDiabetesDiabetes Mellitus, Type 2

NCT00676741Novo Nordisk A/S3,809

已完成

不适用

Observational Study of NovoMix® 50 for Treatment of Type 2 Diabetics for 12 MonthsDiabetesDiabetes Mellitus, Type 2

NCT00755833Novo Nordisk A/S270

已完成

不适用

Observational Study on Blood Glucose Control in Patients With Diabetes Using Modern InsulinDiabetesDiabetes Mellitus, Type 2

NCT00670722Novo Nordisk A/S6,500

已完成

不适用

Observational Study on Effectiveness and Safety of Liraglutide in Subjects With Type 2 DiabetesDiabetesDiabetes Mellitus, Type 2

NCT01288326Novo Nordisk A/S254